Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38167, first published .
Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review

Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review

Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review

Jonathan E Constance   1 , PhD ;   Mary M McFarland   2 , BSc ;   Tallie Casucci   3 , MLIS ;   Michael W Deininger   4, 5 , MD, PhD ;   Elena Y Enioutina   1 , MD, PhD ;   Kathleen Job   1 , PhD ;   Richard S Lemons   6 , MD, PhD ;   Carol S Lim   7 , PhD ;   Robert M Ward   1 , MD ;   Venkata Yellepeddi   1 , PhD ;   Kevin M Watt   1 , MD, PhD

1 Division of Clinical Pharmacology, Department of Pediatrics, University of Utah, Salt Lake City, UT, United States

2 Spencer S. Eccles Health Science Library, University of Utah, Salt Lake City, UT, United States

3 J Willard Marriott Library, University of Utah, Salt Lake City, UT, United States

4 Versiti Blood Research Institute, Milwaukee, WI, United States

5 Division of Hematology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, United States

6 Division of Hematology and Oncology, Department of Pediatrics, University of Utah, Salt Lake City, UT, United States

7 Department of Molecular Pharmaceutics, College of Pharmacy, University of Utah, Salt Lake City, UT, United States

Corresponding Author:

  • Jonathan E Constance, PhD
  • Division of Clinical Pharmacology
  • Department of Pediatrics
  • University of Utah
  • 295 Chipeta Way
  • Salt Lake City, UT, 84108
  • United States
  • Phone: 1 8017128088
  • Email: jonathan.constance@utah.edu